Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Louis Botte"'
Autor:
Jean Michel J.M. Devoitille, Andre De Nayer, M. Ansseau, Marie Anne Gérard, P. Darimont, Jules de Wilde, Jean Pierre J.P. Couzinier, C. Serre, Charles Toussaint, Jean Paul J.P. Demarez, B. Troisfontaines, Louis Botte, Jean-Luc Evrard, C. Mertens, J. Mirel, Remy von Frenckell
Publikováno v:
European Neuropsychopharmacology. 1:113-121
A multicenter controlled study was designed to test the hypothesis that a loading dose of an antidepressant could shorten the latency of its clinical efficacy. Three parallel groups of about 40 endogenous depressive inpatients received either a loadi
Autor:
C. Wolfrum, Mathias Berger, Louis Botte, Patrick Mesters, John G. Salt Lake City Ward, K. Hellstern, Christian Gilles, Jean-Luc Evrard
Publikováno v:
Acta psychiatrica Scandinavica. Supplementum. 360
Moclobemide was compared with placebo for antidepressant activity, tolerance and safety in 2 parallel groups of 23 and 24 depressed patients. At the end of treatment (4 weeks or longer), 9 patients on moclobemide (41%) showed an improvement greater t
Autor:
P. Darimont, Jean-Paul Demarez, C. Serre, Louis Botte, C. Mertens, Emile Meurice, Marc Ansseau, J. M. Devoitille, Jean-Pierre Couzinier, J. Mirel, Andre De Nayer, Remy von Frenckell, Guy Dejaiffe, Marcel Parent, Jules de Wilde, Jean-Luc Evrard
Publikováno v:
Psychopharmacology. 98:163-168
A multicenter study compared the antidepressant efficacy and the tolerance of two doses of milnacipran (50 mg and 100 mg/day) and amitriptyline (150 mg/day) in three parallel groups of 45 major depressive inpatients defined by Research Diagnostic Cri
Autor:
J. P. Demarez, M. Ansseau, Arlette Lecoq, S. Koch-Bourdouxhe, Patrick Papart, R. von Frenckell, P. Darimont, C. Serre, Louis Botte, C. Mertens, J. De Wilde, J. M. Devoitille, J. Mirel, J. L. Evrard, Jean-Pierre Couzinier, A. De Nayer
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 4:221-227
A multicentre study compared the antidepressant efficacy and the tolerance of milnacipran (200 mg/d) and amitriptyline (150 mg/d) in two parallel groups of 43 major depressive inpatients, endogenous subtype, as defined by Research Diagnostic Criteria